| TG THERAPEUTICS, INC. (TGTX) | |||||||||||||||||||||||||||||||||||||||||||||||||
| Q1-CY2026 | Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 | Q1-CY2014 | |
| Balance Sheet Date | 2025-Dec-31 | 2025-Sep-30 | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | 2023-Sep-30 | 2023-Jun-30 | 2023-Mar-31 | 2022-Dec-31 | 2022-Sep-30 | 2022-Jun-30 | 2022-Mar-31 | 2021-Dec-31 | 2021-Sep-30 | 2021-Jun-30 | 2021-Mar-31 | 2020-Dec-31 | 2020-Sep-30 | 2020-Jun-30 | 2020-Mar-31 | 2019-Dec-31 | 2019-Sep-30 | 2019-Jun-30 | 2019-Mar-31 | 2018-Dec-31 | 2018-Sep-30 | 2018-Jun-30 | 2018-Mar-31 | 2017-Dec-31 | 2017-Sep-30 | 2017-Jun-30 | 2017-Mar-31 | 2016-Dec-31 | 2016-Sep-30 | 2016-Jun-30 | 2016-Mar-31 | 2015-Dec-31 | 2015-Sep-30 | 2015-Jun-30 | 2015-Mar-31 | 2014-Dec-31 | 2014-Sep-30 | 2014-Jun-30 | 2014-Mar-31 | |
| Fiscal Period | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | Q3-FY2023 | Q2-FY2023 | Q1-FY2023 | Q4-FY2022 | Q3-FY2022 | Q2-FY2022 | Q1-FY2022 | Q4-FY2021 | Q3-FY2021 | Q2-FY2021 | Q1-FY2021 | Q4-FY2020 | Q3-FY2020 | Q2-FY2020 | Q1-FY2020 | Q4-FY2019 | Q3-FY2019 | Q2-FY2019 | Q1-FY2019 | Q4-FY2018 | Q3-FY2018 | Q2-FY2018 | Q1-FY2018 | Q4-FY2017 | Q3-FY2017 | Q2-FY2017 | Q1-FY2017 | Q4-FY2016 | Q3-FY2016 | Q2-FY2016 | Q1-FY2016 | Q4-FY2015 | Q3-FY2015 | Q2-FY2015 | Q1-FY2015 | Q4-FY2014 | Q3-FY2014 | Q2-FY2014 | Q1-FY2014 | |
| Price to Sales | 7.80x | 7.68x | 10.77x | 12.59x | 16.02x | 14.24x | 13.67x | 7.93x | 8.11x | 11.07x | 6.65x | 154.30x | 256.83x | 617.08x | 171.29x | 88.39x | 171.84x | 406.24x | 1,078.53x | 2,274.98x | 7,492.76x | 44,974.84x | 22,271.93x | 14,592.67x | 7,071.49x | 7,260.78x | 3,500.33x | 5,175.22x | 4,433.55x | 2,236.04x | 3,037.59x | 6,736.07x | 7,048.31x | 72,418.57x | 3,058.52x | ||||||||||||||
| Price to Book | 7.42x | 7.31x | 9.44x | 20.68x | 26.09x | 21.06x | 18.84x | 15.48x | 14.65x | 16.11x | 7.66x | 91.74x | 80.24x | 29.32x | 8.57x | 4.77x | 7.98x | 11.46x | 15.25x | 14.33x | 15.26x | 13.16x | 19.84x | 11.42x | - | 28.58x | - | 59.57x | 35.00x | 14.14x | 6.44x | 10.10x | 12.57x | 8.65x | 10.23x | ||||||||||||||
| Price to Earnings | 10.75x | 10.59x | 12.81x | 94.56x | 158.13x | 200.32x | - | 28.73x | 56.94x | 204.06x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | ||||||||||||||
| Price to Unlevered FCF | - | - | - | - | - | - | - | 40.54x | 115.65x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||
| Debt to Asset Ratio | .39x | .41x | .61x | .64x | .62x | .67x | .56x | .57x | .51x | .50x | .82x | .86x | .70x | .54x | .49x | .44x | .38x | .24x | .20x | .19x | .17x | .38x | .34x | 1.01x | .76x | 1.28x | .88x | .84x | .71x | .37x | .28x | .30x | .31x | .22x | .23x | .18x | .35x | .25x | .17x | .11x | .10x | .09x | .09x | .09x | .08x | .13x | .07x | .06x | |
| Current Ratio | 4.10x | 3.82x | 3.86x | 4.02x | 6.25x | 4.59x | 3.58x | 3.62x | 5.92x | 5.53x | 2.87x | 2.93x | 3.16x | 5.02x | 4.68x | 4.43x | 5.06x | 4.24x | 5.20x | 5.78x | 6.99x | 3.35x | 4.16x | 1.39x | 1.77x | 1.00x | 1.69x | 1.72x | 2.03x | 2.73x | 3.68x | 3.51x | 3.34x | 4.93x | 4.67x | 6.03x | 3.01x | 4.23x | 4.93x | 7.94x | 8.25x | 10.81x | 11.26x | 12.12x | 16.64x | 8.61x | 18.91x | 28.30x | |